- You can view the full Shire Ratings Report.
- Use our drugs section to find industry-relevant news.
- Or find some new ideas from our top rated stocks lists.
- Find other investment ideas from our top rated ETFs lists.
With a boost from the NFL and its own IPO, Quanterix hopes to engage biopharma companies to use its platform to speed safety and efficacy results for neurology, oncology and inflammation pipelines.
Biotech M&A activity will pick up markedly in 2018, and these companies are likely to be the most active in that space.
Roche sees success in trials for its cancer and hemophilia drugs
Cooperman founded Omega Advisers in 1991.